Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Laparoscopy
  • Nephrectomy
  • Robotic Surgical Procedures

abstract

  • Increased monitoring among men with mPCa significantly increases health care costs, without a definitive improvement in survival nor quality of care at EOL noted. Monitoring for disease progression outside of clinical trials should be reserved for those in whom findings will change management. Cancer 2018. © 2018 American Cancer Society.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.31297

PubMed ID

  • 29579318

Additional Document Info